{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:18:19Z","timestamp":1779398299373,"version":"3.53.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.japh.2025.102979","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:44:11Z","timestamp":1762307051000},"page":"102979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring workflows for long-acting antiretroviral therapy administration in community pharmacies"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7136-5686","authenticated-orcid":false,"given":"Valerie","family":"Clinard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5684-3883","authenticated-orcid":false,"given":"Kevin","family":"Bumanglag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3793-5112","authenticated-orcid":false,"given":"Parya","family":"Saberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-4224","authenticated-orcid":false,"given":"Kelly","family":"Hester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8824-8057","authenticated-orcid":false,"given":"Michael","family":"Sigua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5797-7849","authenticated-orcid":false,"given":"George","family":"Udeani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6559-0684","authenticated-orcid":false,"given":"Elizabeth","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5674-4741","authenticated-orcid":false,"given":"Yvette","family":"Cuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4003-1939","authenticated-orcid":false,"given":"Jennifer","family":"Cocohoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2025.102979_bib1","doi-asserted-by":"crossref","DOI":"10.1177\/23259582211009011","article-title":"The promise of improved adherence with long-acting antiretroviral therapy: what are the data?","volume":"20","author":"Scarsi","year":"2021","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"10","key":"10.1016\/j.japh.2025.102979_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/09564624231169329","article-title":"Barriers to adherence to antiretroviral therapy: identifying priority areas for people with HIV and healthcare professionals","volume":"34","author":"Mate","year":"2023","journal-title":"Int J STD AIDS"},{"issue":"5","key":"10.1016\/j.japh.2025.102979_bib3","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/S2352-3018(23)00051-6","article-title":"Long-acting antiretrovirals and HIV treatment adherence","volume":"10","author":"Nachega","year":"2023","journal-title":"Lancet HIV"},{"key":"10.1016\/j.japh.2025.102979_bib4","author":"Czarnogorski"},{"issue":"3","key":"10.1016\/j.japh.2025.102979_bib5","doi-asserted-by":"crossref","first-page":"e645","DOI":"10.1093\/cid\/ciac631","article-title":"First demonstration Project of long-acting injectable antiretroviral therapy for persons with and without detectable Human Immunodeficiency Virus (HIV) viremia in an urban HIV clinic","volume":"76","author":"Christopoulos","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.japh.2025.102979_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QAD.0000000000003446","article-title":"Single-center experience evaluating and initiating people with HIV on long-acting cabotegravir\/rilpivirine","volume":"37","author":"Hill","year":"2023","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.japh.2025.102979_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac455","article-title":"Early experience implementing long-acting injectable cabotegravir\/rilpivirine for human immunodeficiency Virus-1 treatment at a ryan white-funded clinic in the US south","volume":"9","author":"Collins","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.japh.2025.102979_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.2021-9-2","article-title":"Experiences to date with the logistical management of long-acting cabotegravir and rilpivirine","volume":"11","author":"Johnson","year":"2022","journal-title":"DIC"},{"issue":"6","key":"10.1016\/j.japh.2025.102979_bib9","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.japh.2022.07.003","article-title":"Access to community pharmacies: a nationwide geographic information systems cross-sectional analysis","volume":"62","author":"Berenbrok","year":"2022","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.japh.2025.102979_bib12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1186\/s12913-025-12971-8","article-title":"Preparing for pharmacy-based delivery of long-acting injectable antiretrovirals: a pre-implementation study","volume":"25","author":"Cocohoba","year":"2025","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.japh.2025.102979_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.japh.2025.102979_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","article-title":"The updated Consolidated Framework for Implementation Research based on user feedback","volume":"17","author":"Damschroder","year":"2022","journal-title":"Implement Sci"},{"issue":"5","key":"10.1016\/j.japh.2025.102979_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.sapharm.2017.06.001","article-title":"Application of the Consolidated Framework for Implementation Research to community pharmacy: a framework for implementation research on pharmacy services","volume":"13","author":"Shoemaker","year":"2017","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.japh.2025.102979_bib16","series-title":"Psychology\u00ae. American Psychological Association","first-page":"57","article-title":"Thematic analysis. APA Handbook of Research Methods in Psychology, Vol 2: Research Designs: Quantitative, Qualitative, Neuropsychological, and Biological. APA Handbooks in","author":"Braun","year":"2012"},{"key":"10.1016\/j.japh.2025.102979_bib17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12913-021-06254-1","article-title":"Process mapping in healthcare: a systematic review","volume":"21","author":"Antonacci","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.japh.2025.102979_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1152556","article-title":"Pharmacy-based immunization: a systematic review","volume":"11","author":"Romero-Mancilla","year":"2023","journal-title":"Front Public Health"},{"issue":"3","key":"10.1016\/j.japh.2025.102979_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.japh.2022.08.006","article-title":"Systematic review of community pharmacist administration of long-acting injectable antipsychotic medications","volume":"63","author":"Black","year":"2023","journal-title":"J Am Pharm Assoc"},{"issue":"22","key":"10.1016\/j.japh.2025.102979_bib20","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1001\/jama.2022.22569","article-title":"Ending the HIV epidemic: we have the tools, do we have the will?","volume":"328","author":"Haddad","year":"2022","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.japh.2025.102979_bib21","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.1016\/S2352-3018(24)00212-1","article-title":"Global, regional, and national burden of HIV\/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the global burden of disease Study 2021","volume":"11","year":"2024","journal-title":"Lancet HIV"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125006582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T09:32:17Z","timestamp":1770370337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125006582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":19,"alternative-id":["S1544319125006582"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102979","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring workflows for long-acting antiretroviral therapy administration in community pharmacies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"102979"}}